A trial sponsored by the Nottingham University Hospitals National Health Service (NHS) Trust, United Kingdom (UK), is testing a lightweight fiberglass heel cup designed to protect and promote healing of diabetes-related heel ulcers, thus reducing the risk of amputation. The heel cup cast is being tested in 30 hospitals. The trial is expected to run for approximately one year and involve more than 500 patients. Funding is being provided by the UK’s Department of Health.
